Evidence map›Paper›PMID 40883509›Full record

ArticleEMBO reports2025

Nrm1 is a bistable switch connecting cell cycle progression to transcriptional control.

Guillem Murciano-Julià, Montserrat Vega, Esther Pazo, Àlex Pascual-Serra, Isabel Alves-Rodrigues, Oriol Bagudanch, Roger Anglada, Núria Bonet, Rosa Aligué, Sergio Moreno and 3 more

Abstract read
In one paragraph

Article in EMBO reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Guillem Murciano-JuliàOxidative Stress and Cell Cycle Group, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0000-0002-7399-470X
Montserrat VegaOxidative Stress and Cell Cycle Group, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0000-0002-4837-0671
Esther PazoOxidative Stress and Cell Cycle Group, Universitat Pompeu Fabra, Barcelona, Spain.
Àlex Pascual-SerraDepartment of Biomedical Science, University of Barcelona, Barcelona, Spain.
Isabel Alves-RodriguesOxidative Stress and Cell Cycle Group, Universitat Pompeu Fabra, Barcelona, Spain.
Oriol BagudanchOxidative Stress and Cell Cycle Group, Universitat Pompeu Fabra, Barcelona, Spain.
Roger AngladaGenomics Core Facility, Universitat Pompeu Fabra, Barcelona, Spain.
Núria BonetGenomics Core Facility, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0000-0003-0574-2575
Rosa AliguéDepartment of Biomedical Science, University of Barcelona, Barcelona, Spain.
Sergio MorenoInstituto de Biología Funcional y Genómica, CSIC, University of Salamanca, Salamanca, Spain.ORCID 0000-0002-8039-1413
Baldo OlivaStructural Bioinformatics Lab (GRIB), Universitat Pompeu Fabra, Barcelona, Spain.
Elena HidalgoOxidative Stress and Cell Cycle Group, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0000-0002-3768-6785
José AytéOxidative Stress and Cell Cycle Group, Universitat Pompeu Fabra, Barcelona, Spain. jose.ayte@upf.edu.ORCID 0000-0002-6354-0536

Funding

Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) 2021-SGR-00007Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) FI predoctoral fellowshipInstitució Catalana de Recerca i Estudis Avançats (ICREA) ICREA AcademiaMinisterio de Ciencia, Innovación y Universidades (MCIU) CEX2018-000792-MMinisterio de Ciencia, Innovación y Universidades (MCIU) PID2022-136449NB-I00
6 · The paper itself

Abstract

Entry into the cell cycle requires activation of G1 cyclin-dependent kinases (CDKs) and the G1/S transcriptional program. In fission yeast, the MBF complex is the main transcription factor driving early cell-cycle gene expression. MBF-dependent transcription is activated in metaphase and repressed at the end of S phase by a feedback loop involving the cyclin Cig2 and co-repressors Nrm1 and Yox1. While replicative stress inactivates Yox1 via phosphorylation, the mechanism that activates MBF during an unperturbed cell cycle remains unclear. Here, we identify Nrm1 as the key target of cell cycle regulation in a two-step control mechanism. First, CDK1 phosphorylates Nrm1 in metaphase, leading to its release-along with Yox1-from chromatin. Second, unphosphorylated Nrm1, generated either by dephosphorylation or de novo synthesis, is degraded during anaphase, preventing its re-association with MBF until the end of the next S phase. Together, these parallel pathways create a precisely timed window of MBF activation, ensuring proper cell cycle progression and preserving genomic stability.

Indexed as

Cell CycleGene Expression Regulation, FungalSchizosaccharomycesSchizosaccharomyces pombe ProteinsTranscription FactorsTranscription, GeneticCDC2 Protein KinaseChromatinPhosphorylationCDC2 Protein Kinasecdc2 protein, S pombeChromatinSchizosaccharomyces pombe ProteinsTranscription FactorsAPC/CCDK1MBFNrm1START

Identifiers

PMID40883509
PMCPMC12550009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.